Safety evaluation of changed use levels of the food enzyme triacylglycerol lipase from the non-genetically modified strain AE-LAYH (B).

The food enzyme triacylglycerol lipase (triacylglycerol acylhydrolase; EC 3.1.1.

Safety evaluation of an extension of use of the food enzyme triacylglycerol lipase from the genetically modified strain LFS.

The food enzyme triacylglycerol lipase (triacylglycerol acylhydrolase, EC 3.1.1.

Safety evaluation of an extension of use of the food enzyme glucose oxidase from the genetically modified strain ZGL.

The food enzyme glucose oxidase (β-d-glucose: oxygen 1-oxidoreductase, EC 1.1.3.

Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care.

Introduction: This multicenter prospective study sponsored by the (GETH-TC) explores the use of frailty assessments in allo-HCT candidates.

Methods: Frailty was measured using the HCT Frailty Scale at first consultation and HCT admission in 404 adults from 15 HCT programs in Spain. Based on the results, patients were classified into fit, pre-frail and frail categories.

Characteristics, outcomes and treatment patterns in acute myeloid leukemia patients 60 years or older in Colombia: a RENEHOC-PETHEMA study.

There is a limited information available on the clinical characteristics, treatment patterns and outcomes on older patients diagnosed with Acute Myeloid Leukemia (AML) in Latin-America. This multicenter retrospective study analyzed 269 patients over 60 years of age diagnosed with AML in Colombia, using data from RENEHOC-PETHEMA registry, from 2009 to 2023. The median age at diagnosis was 70 years (Range:60-98), 55% were men, 61% had an ECOG < 2, and 75.